Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News TNF Pharmaceuticals Inc TNFA

Healthcare
TNF Pharmaceuticals, Inc., formerly MyMD Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company focused on developing novel therapies for age-related diseases and autoimmune and inflammatory conditions. It is focused on developing and commercializing two therapeutic platforms based on well-defined therapeutic targets: MYMD-1 and Supera-CBD. MYMD-1 is a drug platform based on a... see more

Recent & Breaking News (NDAQ:TNFA)

Akers Biosciences Further Extends Outsourced US Distribution Capabilities for Heparin PF4 Rapid Test

GlobeNewswire July 3, 2018

AKERS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Akers Biosciences, Inc. to Contact the Firm

Business Wire June 29, 2018

Akers Biosciences Requests Temporary Suspension of Trading on London Stock Exchange

GlobeNewswire June 29, 2018

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Unum Group To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

Business Wire June 28, 2018

INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Akers Biosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire June 25, 2018

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Unum Group (UNM) & Lead Plaintiff Deadline – August 13, 2018

GlobeNewswire June 22, 2018

Pomerantz Law Firm Announces the Filing of a Class Action against Akers Biosciences, Inc. and Certain Officers –  AKER

GlobeNewswire June 20, 2018

Safirstein Metcalf LLP Announces that a Class Action Has Been Filed Against Akers Biosciences, Inc. – AKER

GlobeNewswire June 20, 2018

Akers Alert: Bernstein Liebhard LLP Announces Investigation of Akers Biosciences, Inc. - AKER

GlobeNewswire June 20, 2018

AKERS BIOSCIENCES, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey against Akers Biosciences, Inc.

GlobeNewswire June 19, 2018

AKER LOSS NOTICE: Rosen Law Firm Files First Securities Class Action Lawsuit Against Akers Biosciences, Inc. – AKER

Business Wire June 19, 2018

Akers Class Action: Bernstein Liebhard LLP Announces That a Securities Class Action Lawsuit Has Been Filed Against Akers Biosciences, Inc. - AKER

GlobeNewswire June 19, 2018

Robbins Arroyo LLP: Akers Biosciences, Inc. (AKER) Misled Shareholders According to a Recently Filed Class Action

Business Wire June 18, 2018

SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Akers Biosciences, Inc. (Nasdaq: AKER) To Contact Brower Piven Before The Lead Plaintiff Deadline

GlobeNewswire June 18, 2018

AKERS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Akers Biosciences, Inc. To Contact The Firm

PR Newswire June 15, 2018

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against TAL Education Group and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire June 15, 2018

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of China Zenix Auto International Limited - ZX

Canada NewsWire June 15, 2018

Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Akers Biosciences, Inc. (AKER) and Encourages Investors to Contact the Firm

GlobeNewswire June 14, 2018

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Ormat Technologies, Inc. (ORA) & Lead Plaintiff Deadline – August 10, 2018

GlobeNewswire June 14, 2018

Akers Class Action: Bernstein Liebhard LLP Announces That A Securities Class Action Lawsuit Has Been Filed Against Akers Biosciences, Inc. - AKER

PR Newswire June 13, 2018